Incyte
INCY
#1203
Rank
C$26.30 B
Marketcap
C$131.68
Share price
1.72%
Change (1 day)
53.58%
Change (1 year)

Earnings for Incyte (INCY)

Earnings in 2025 (TTM): C$2.30 Billion

According to Incyte's latest financial reports the company's current earnings are C$5.14 Billion. , an increase over its 2024 earnings that were of C$0.43 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Incyte from 1994 to 2025

Annual earnings

Year Earnings Change
2025 C$2.26 B425.68%
2024 C$0.43 B-62.04%
2023 C$1.13 B57.66%
2022 C$0.71 B-7.24%
2021 C$0.77 B-345.65%
2020 -C$0.32 Billion-147.7%
2019 C$0.66 B322.02%
2018 C$0.15 B-136.94%
2017 -C$0.43 Billion-390.76%
2016 C$0.14 B1322%
2015 C$10.26 M-115.56%
2014 -C$65.97 Million-41.4%
2013 -C$0.12 Billion87.67%
2012 -C$59.99 Million-74.9%
2011 -C$0.24 Billion843.59%
2010 -C$25.33 Million-88.68%
2009 -C$0.23 Billion1.37%
2008 -C$0.23 Billion86.16%
2007 -C$0.12 Billion17.64%
2006 -C$0.11 Billion-28.62%
2005 -C$0.15 Billion-36.1%
2004 -C$0.23 Billion-2.03%
2003 -C$0.23 Billion22.26%
2002 -C$0.19 Billion-27.39%
2001 -C$0.26 Billion198.72%
2000 -C$85.05 Million132.2%
1999 -C$36.63 Million-556.86%
1998 C$8.01 M-37.23%
1997 C$12.77 M-259.32%
1996 -C$8.02 Million-45.87%
1995 -C$14.82 Million-9.17%
1994 -C$16.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.21 B 882.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$13.84 B 512.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$34.96 B 1,445.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.19 B 439.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.22 B-90.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-C$69.09 Million-103.05%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-C$94.09 Million-104.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-C$39.46 Million-101.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$82.39 Million-103.64%๐Ÿ‡บ๐Ÿ‡ธ USA